BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12390997)

  • 1. Diagnosis of Down's syndrome in neonates.
    Hindley D; Medakkar S
    Arch Dis Child Fetal Neonatal Ed; 2002 Nov; 87(3):F220-1. PubMed ID: 12390997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
    Haddow JE; Palomaki GE; Knight GJ; Foster DL; Neveux LM
    J Med Screen; 1998; 5(3):115-9. PubMed ID: 9795869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interference in the autoDELFIA(R) hAFP immunoassay and effect on second-trimester Down's syndrome screening.
    Mannings L; Trow S; Newman J; Nix B; Evans C
    Ann Clin Biochem; 2011 Sep; 48(Pt 5):438-40. PubMed ID: 21795408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective clinical trial to compare the performance of dried blood spots prenatal screening for Down's syndrome with conventional non-invasive testing technology.
    Hu H; Jiang Y; Zhang M; Liu S; Hao N; Zhou J; Liu J; Zhang X; Ma L
    Exp Biol Med (Maywood); 2017 Mar; 242(5):547-553. PubMed ID: 28056555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical diagnosis of Down's syndrome.
    Jackson JF; North ER; Thomas JG
    Clin Genet; 1976 May; 9(5):483-7. PubMed ID: 131663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal serum markers for Down's syndrome pregnancies.
    Chew S; Anandakumar C; Ratnam SS
    Singapore Med J; 1995 Aug; 36(4):417-23. PubMed ID: 8919160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study of prenatal screening for Down's syndrome with free beta human chorionic gonadotrophin.
    Spencer K; Carpenter P
    BMJ; 1993 Sep; 307(6907):764-9. PubMed ID: 7693095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antenatal screening for Down's syndrome with the quadruple test.
    Wald NJ; Huttly WJ; Hackshaw AK
    Lancet; 2003 Mar; 361(9360):835-6. PubMed ID: 12642052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of prenatal diagnosis: rapid testing or full karyotype? An audit of chromosome abnormalities and pregnancy outcomes for women referred for Down's Syndrome testing.
    Ogilvie CM; Lashwood A; Chitty L; Waters JJ; Scriven PN; Flinter F
    BJOG; 2005 Oct; 112(10):1369-75. PubMed ID: 16167939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of non-invasive prenatal testing as a contingent approach on the indications for invasive prenatal diagnosis and prenatal detection rate of Down's syndrome.
    Kou KO; Poon CF; Kwok SL; Chan KY; Tang MH; Kan AS; Leung KY
    Hong Kong Med J; 2016 Jun; 22(3):223-30. PubMed ID: 27149976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of first year (1989) of a national register of Down's syndrome in England and Wales.
    Mutton DE; Alberman E; Ide R; Bobrow M
    BMJ; 1991 Nov; 303(6813):1295-7. PubMed ID: 1836152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
    Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
    N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
    Lamlertkittikul S; Chandeying V
    J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of clinical diagnosis in Down's syndrome.
    Sivakumar S; Larkins S
    Arch Dis Child; 2004 Jul; 89(7):691. PubMed ID: 15210514
    [No Abstract]   [Full Text] [Related]  

  • 15. Antenatal maternal serum screening for Down's syndrome: results of a demonstration project.
    Wald NJ; Kennard A; Densem JW; Cuckle HS; Chard T; Butler L
    BMJ; 1992 Aug; 305(6850):391-4. PubMed ID: 1382768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
    Hsu JJ; Hsieh TT; Soong YK; Spencer K
    Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analysis of 142 cases.
    Nyberg DA; Luthy DA; Resta RG; Nyberg BC; Williams MA
    Ultrasound Obstet Gynecol; 1998 Jul; 12(1):8-14. PubMed ID: 9697277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal bilirubin production, reflected by carboxyhaemoglobin concentrations, in Down's syndrome.
    Kaplan M; Vreman HJ; Hammerman C; Stevenson DK
    Arch Dis Child Fetal Neonatal Ed; 1999 Jul; 81(1):F56-60. PubMed ID: 10375364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevention of Down's syndrome in the south western region of England 1975-1985.
    Wilson N; Bickley D; McDermott A
    West Engl Med J; 1990 Mar; 105(1):15-7. PubMed ID: 2141994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for Down's syndrome and neural tube defect in Croatia. A regional prospective study.
    Brajenović-Milić B; Tislarić D; Bacić J; Paravić J; Slivar AE; Kapovic M; Kosec V; Ristic S; Rajhvajn B
    Fetal Diagn Ther; 1998; 13(6):367-71. PubMed ID: 9933821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.